D
KalVista Pharmaceuticals, Inc. KALV
$13.05 -$0.26-1.95% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

04/30/2025 01/31/2025 10/31/2024 07/31/2024 04/30/2024
Net Income -183.44M -175.87M -156.39M -141.77M -126.64M
Total Depreciation and Amortization 941.00K 899.00K 877.00K 847.00K 816.00K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 14.56M 27.21M 19.49M 21.13M 21.43M
Change in Net Operating Assets 15.04M 20.11M 13.48M 17.08M 15.17M
Cash from Operations -152.91M -127.65M -122.54M -102.72M -89.23M
Capital Expenditure -434.00K -168.00K -163.00K -57.00K -42.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 91.46M -31.67M -46.89M -67.11M -84.68M
Cash from Investing 91.02M -31.83M -47.05M -67.17M -84.72M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 61.69M 156.81M 100.55M 100.39M 97.59M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 98.04M 148.35M 53.12M 53.12M 53.12M
Cash from Financing 159.73M 305.17M 153.68M 153.51M 150.71M
Foreign Exchange rate Adjustments 2.64M -799.00K -171.00K -1.18M -1.21M
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 100.48M 144.89M -16.09M -17.56M -24.45M